Nemonapride

Nemonapride

Systematic (IUPAC) name
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
Clinical data
Trade names	Emilace (JP)
AHFS/Drugs.com	International Drug Names
Legal status	Rx-only (JP)
Routes of administration	Oral
Identifiers
CAS Number	75272-39-8
ATC code	None
PubChem	CID 4452
IUPHAR/BPS	983
UNII	Q88T5P3444 Y
KEGG	D01468 Y
Chemical data
Formula	C21H26ClN3O2
Molar mass	387.90 g/mol
SMILES CC1C(CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl
(verify)

Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D₂ and D₃ receptor antagonist, and is also a potent 5-HT_1A receptor agonist. It has affinity for sigma receptors.

See also

• Benzamide

References